Gullberg R
Clin Exp Immunol. 1971 Dec;9(6):833-8.
The disturbing effect of vitamin B binding to test serum in assay of type I antibody to intrinsic factor was reduced by pre-treatment of the serum. The B-binding sites of serum proteins were blocked by adding unlabelled cyanocobalamin, the unbound excess of which was adsorbed to albumin-coated charcoal. Using an earlier described sensitive small-scale gel filtration technique for antibody assay, it was possible to decrease the smallest amount of antibody demonstrable from 2 to 0·5 ng B units per ml of serum by the pre-treatment of serum. This four-fold increase in sensitivity implied that the positive results rose from 60% to 76% in a material of twenty-five pernicious-anaemia patients. No positive results were obtained in thirty-four control subjects or in a serum pool from twenty blood donors. The pre-treatment, including charcoal adsorption of unbound B, also eliminated the risk of false-positive results because of recent B injection.
在检测内因子I型抗体时,通过对血清进行预处理,可降低维生素B与检测血清结合所产生的干扰效应。通过添加未标记的氰钴胺来封闭血清蛋白的B结合位点,过量未结合的氰钴胺被吸附到白蛋白包被的活性炭上。使用先前描述的用于抗体检测的灵敏小规模凝胶过滤技术,通过血清预处理可将每毫升血清中可检测到的最小抗体量从2纳克B单位降至0.5纳克B单位。灵敏度提高了四倍,这意味着在25例恶性贫血患者的样本中,阳性结果从60%升至76%。在34名对照受试者或20名献血者的混合血清中未获得阳性结果。包括对未结合B进行活性炭吸附在内的预处理,还消除了因近期注射B而导致假阳性结果的风险。